India [August XX, 2025] – Terumo India, the Indian subsidiary of Terumo Corporation (TSE: 4543), a global leader in medical technology, has launched Terufusion™ Advanced Infusion Systems in India for the first time.
This connected infusion system combines a Smart Syringe Pump, Smart Infusion Pump (Volumetric), and Pump Monitoring System (PMS) software to enable precise and efficient drug administration.
Designed to enhance drug delivery accuracy, improve patient safety, and optimize clinical workflows, the system integrates Terumo’s trusted global infusion technology with intelligent digital capabilities such as remote monitoring, customizable dose modes, and an integrated drug library.
Advancing Critical Care in IndiaAs India’s critical care infrastructure evolves with over 95,000 ICU beds and increasing investment in high-dependency care, there is a growing demand for smarter, safer, and more efficient drug delivery systems.
Terufusion™ Advanced Infusion Systems are designed to support hospitals in transitioning toward smarter, more transparent ICU operations.
Leadership Perspective
Mr. Shishir Agarwal, President and Managing Director, Terumo India, said:
“At Terumo India, our Brand Promise has always been about ‘Unwavering Commitment to Patients’. With this launch, we are taking a meaningful step forward in bringing global innovation to support India’s critical care infrastructure. Expanding into smart, connected technologies is a natural progression of our commitment to serve patients and healthcare providers more holistically, and to advance healthcare systems that are future-ready, inclusive, and clinically impactful.”
Designed for Clinical EfficiencyThe Terufusion™ Advanced Infusion Systems address everyday challenges faced by nursing staff by providing:
- Greater control and visibility in drug delivery
- Reduced manual errors through smart automation
- Simplified pump management across ICU environments
This advanced system enhances workflow efficiency while improving patient safety and confidence among healthcare professionals.
Terumo India is actively collaborating with leading hospitals across the country to implement Terufusion™ systems in advanced critical care management.
Mr. Dharampal Singh Rawat, Senior Director – Cardiovascular, Terumo Aortic and Medication Management, added:
“With evolving disease patterns and treatment timelines, clinicians must make faster decisions, and technology must support them. There is a growing need for solutions that combine precision with simplicity. Terufusion™ Advanced Infusion Systems are designed to help healthcare professionals deliver safer, more efficient care with confidence.”
Commitment to InnovationWith this launch, Terumo India reinforces its commitment to equipping hospitals with intelligent, high-precision technologies that address the growing complexity of critical care.
In the past two years, the company has introduced several key innovations, including:
- TREO Abdominal Stent-Graft System
- Ultimaster Nagomi Drug-Eluting Stent
These innovations demonstrate Terumo’s continued focus on delivering world-class, patient-centric healthcare solutions.
About Terumo India
Terumo India is a rapidly growing medical devices company dedicated to advancing access to high-quality cardiac, vascular, and other medical devices for patients and healthcare practitioners in India. As part of Terumo Corporation, headquartered in Tokyo, Japan, the company continues its mission of ‘Contributing to Society through Healthcare.’
Established in 2013 and headquartered in Gurgaon, NCR Delhi, Terumo India has impacted over 100,000 lives. The company is four times Great Place to Work® certified and has been recognized among India’s Top 15 Workplaces™ in Pharmaceuticals, Healthcare, and Biotech.
Terumo India actively runs training and development programs in collaboration with customers and academic partners to support the evolving needs of India’s healthcare ecosystem.
For more information, visit: https://terumoindia.com/
About Terumo
Terumo (TSE: 4543) is a global leader in medical technology and has been committed to “Contributing to Society through Healthcare” for over 100 years.
Based in Tokyo and operating in more than 160 countries, Terumo provides innovative solutions across vascular intervention, cardio-surgical care, blood transfusion, and daily clinical practice.
For more information, visit: https://www.terumo.com/
